BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24962819)

  • 1. Sustained local delivery of oncolytic short hairpin RNA adenoviruses for treatment of head and neck cancer.
    Jung SH; Choi JW; Yun CO; Yhee JY; Price R; Kim SH; Kwon IC; Ghandehari H
    J Gene Med; 2014; 16(5-6):143-52. PubMed ID: 24962819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
    Yoo JY; Kim JH; Kwon YG; Kim EC; Kim NK; Choi HJ; Yun CO
    Mol Ther; 2007 Feb; 15(2):295-302. PubMed ID: 17235307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.
    Choi JW; Kang E; Kwon OJ; Yun TJ; Park HK; Kim PH; Kim SW; Kim JH; Yun CO
    Gene Ther; 2013 Sep; 20(9):880-92. PubMed ID: 23514707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
    Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
    Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
    Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
    J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
    Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
    Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
    Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
    J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silk-elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors.
    Greish K; Frandsen J; Scharff S; Gustafson J; Cappello J; Li D; O'Malley BW; Ghandehari H
    J Gene Med; 2010 Jul; 12(7):572-9. PubMed ID: 20603862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.
    Kim J; Li Y; Kim SW; Lee DS; Yun CO
    Biomaterials; 2013 Jun; 34(19):4622-31. PubMed ID: 23541109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of an oncolytic adenovirus expressing small hairpin RNA and targeting the SATB1 gene].
    Mao LJ; Zheng JN; Li W; Wang JQ; Chen JC; Sun XQ
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):679-83. PubMed ID: 21090340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and real-time imaging of gene expression of adenovirus embedded silk-elastinlike protein polymer hydrogels.
    Cresce Av; Dandu R; Burger A; Cappello J; Ghandehari H
    Mol Pharm; 2008; 5(5):891-7. PubMed ID: 18763804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model.
    Yoon AR; Kasala D; Li Y; Hong J; Lee W; Jung SJ; Yun CO
    J Control Release; 2016 Jun; 231():2-16. PubMed ID: 26951927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors.
    Greish K; Araki K; Li D; O'Malley BW; Dandu R; Frandsen J; Cappello J; Ghandehari H
    Biomacromolecules; 2009 Aug; 10(8):2183-8. PubMed ID: 19722557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.
    Moon CY; Choi JW; Kasala D; Jung SJ; Kim SW; Yun CO
    Biomaterials; 2015 Feb; 41():53-68. PubMed ID: 25522965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression.
    Gustafson J; Greish K; Frandsen J; Cappello J; Ghandehari H
    J Control Release; 2009 Dec; 140(3):256-61. PubMed ID: 19470397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral gene delivery to solid tumors by recombinant silk-elastinlike protein polymers.
    Hatefi A; Cappello J; Ghandehari H
    Pharm Res; 2007 Apr; 24(4):773-9. PubMed ID: 17308969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
    Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
    J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
    Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
    Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.